AVCO Avalon GloboCare Corp

Price (delayed)

$0.46

Market cap

$40.92M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$43.76M

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics ...

Highlights
The EPS has grown by 33% year-on-year and by 9% since the previous quarter
The net income has increased by 25% YoY and by 3.3% from the previous quarter
Avalon GloboCare's quick ratio has shrunk by 74% YoY and by 38% QoQ
The equity has dropped by 72% year-on-year and by 58% since the previous quarter

Key stats

What are the main financial stats of AVCO
Market
Shares outstanding
88.96M
Market cap
$40.92M
Enterprise value
$43.76M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
31.84
Price to sales (P/S)
29.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
31.28
Earnings
Revenue
$1.4M
EBIT
-$8.6M
EBITDA
-$8.15M
Free cash flow
-$4.05M
Per share
EPS
-$0.1
Free cash flow per share
-$0.05
Book value per share
$0.01
Revenue per share
$0.02
TBVPS
$0.11
Balance sheet
Total assets
$9.67M
Total liabilities
$8.39M
Debt
$3.36M
Equity
$1.28M
Working capital
-$4.23M
Liquidity
Debt to equity
2.63
Current ratio
0.18
Quick ratio
0.15
Net debt/EBITDA
-0.35
Margins
EBITDA margin
-582.4%
Gross margin
30.1%
Net margin
-628.7%
Operating margin
-618.9%
Efficiency
Return on assets
-86.5%
Return on equity
-372.3%
Return on invested capital
-96.7%
Return on capital employed
-190.2%
Return on sales
-614.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVCO stock price

How has the Avalon GloboCare stock price performed over time
Intraday
-2.15%
1 week
5.67%
1 month
-8.38%
1 year
-55.77%
YTD
-43.9%
QTD
-34.35%

Financial performance

How have Avalon GloboCare's revenue and profit performed over time
Revenue
$1.4M
Gross profit
$420,821
Operating income
-$8.66M
Net income
-$8.79M
Gross margin
30.1%
Net margin
-628.7%
The company's net margin rose by 27% YoY and by 3.8% QoQ
AVCO's operating margin is up by 26% year-on-year and by 2.6% since the previous quarter
The net income has increased by 25% YoY and by 3.3% from the previous quarter
AVCO's operating income is up by 25% year-on-year

Growth

What is Avalon GloboCare's growth rate over time

Valuation

What is Avalon GloboCare stock price valuation
P/E
N/A
P/B
31.84
P/S
29.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
31.28
The EPS has grown by 33% year-on-year and by 9% since the previous quarter
The equity has dropped by 72% year-on-year and by 58% since the previous quarter
The stock's price to book (P/B) is 6% less than its last 4 quarters average of 34.5
The stock's price to sales (P/S) is 42% less than its last 4 quarters average of 51.6
The revenue has grown by 2.1% YoY

Efficiency

How efficient is Avalon GloboCare business performance
AVCO's return on equity is down by 49% year-on-year and by 31% since the previous quarter
The return on sales has grown by 27% year-on-year and by 3.8% since the previous quarter
AVCO's return on assets is up by 20% year-on-year
AVCO's ROIC is up by 12% YoY but it is down by 4.8% QoQ

Dividends

What is AVCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVCO.

Financial health

How did Avalon GloboCare financials performed over time
The company's total assets is 15% higher than its total liabilities
Avalon GloboCare's quick ratio has shrunk by 74% YoY and by 38% QoQ
The current ratio has dropped by 73% year-on-year and by 40% since the previous quarter
The company's debt is 163% higher than its equity
The debt to equity has soared by 146% QoQ
The equity has dropped by 72% year-on-year and by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.